Eunate Arana‐Arri

Immunogenicity and reactogenicity of BNT162b2 booster in ChAdOx1-S-primed participants (CombiVacS): a multicentre, open-label, randomised, controlled, phase 2 trial

Alberto M. Borobia, Antonio J. Carcas, Mayte Pérez‐Olmeda et al. · The Lancet · 2021 · 386 citations · Full text

Veterinary Medicine, Immunology, Infectious Diseases +17

SARS-CoV-2 Infection Dysregulates the Metabolomic and Lipidomic Profiles of Serum

Chiara Bruzzone, Maider Bizkarguenaga, Rubén Gil‐Redondo et al. · iScience · 2020 · 228 citations · Full text

Life Sciences, Biochemistry, Infectious Diseases +17

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 175 citations · Full text

Veterinary Medicine, Infectious Diseases, Molecular Virology +16

International Epidemiological Differences in Acute Poisonings in Pediatric Emergency Departments

Santiago Mintegi, Beatriz Azkunaga, Javier Prego et al. · Pediatric Emergency Care · 2017 · 89 citations · Full text

Public Health, Emergency Medicine, Pediatrics +9

Pilot Clinical Trial of High-Flow Oxygen Therapy in Children with Asthma in the Emergency Service

Yolanda Ballestero, Jimena De Pedro, Nancy Portillo et al. · The Journal of Pediatrics · 2018 · 85 citations

Medicine, Child Health, Pediatrics +14